Related Experiment Video
Updated: Jan 10, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
TGF-β1 Up-Regulates PLAU Expression to Promote Invasion and Migration of Oral Squamous Cell Carcinoma
Gaoren Lin1,2,3, Honglan Wang1,2, Dandan Zhang1,2
1Department of Stomatology, North Sichuan Medical College, Nanchong, China.
Introduction:
Dysregulated expression of urokinase-type plasminogen activator (PLAU), a serine protease, is frequently associated with various cancers. However, in oral squamous cell carcinoma (OSCC), the specific biological functions and mechanisms of action of PLAU remain unclear.
Methods:
Western blot (WB) analysis and quantitative real time polymerase chain reaction experiments verified the protein and mRNA expression of PLAU in oral squamous cell carcinoma; Flow cytometry was used to assess changes in OSCC cell cycle and apoptosis following PLAU knockdown. Transwell assays were conducted to evaluate alterations in cell invasion and migration after PLAU knockdown. LinkedOmics database was employed to analyze the correlation between PLAU and TGF-β1.
Results:
Our study using GEPIA2 dataset analysis and WB experiments revealed that PLAU expression was upregulated in HNSC tissues and OSCC cell lines and was significantly associated with overall survival in patients. Furthermore, the invasive and migratory abilities of UM1 cells were significantly reduced following PLAU knockdown, as demonstrated by scratch assays and Transwell migration assays. Subsequently, Western blot analysis revealed that PLAU knockdown effectively inhibited the epithelial-mesenchymal transition (EMT) process. Meanwhile, LinkedOmics database analysis revealed a significant positive correlation between TGF-β1 and PLAU. Further investigations demonstrated that TGF-β1 induces PLAU upregulation, which subsequently promotes the migration, invasion, and EMT process in OSCC cells. Conversely, PLAU knockdown abrogates these TGF-β1-mediated effects.
Conclusion:
PLAU acts as a key oncogenic driver in OSCC and may serve as a potential diagnostic and prognostic biomarker. More importantly, the TGF-β1-PLAU axis may offer new therapeutic targets for OSCC treatment.
Related Concept Videos
TGF - β Signaling Pathway
Intracellular Signaling Affects Focal Adhesions
Some...
Induced Pluripotent Stem Cells
Somatic...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cytoskeletal Linker Proteins - Plakins

